Blueprint Medicines Corp (NASDAQ:BPMC)

92.53
Delayed Data
As of 3:59pm ET
 -1.62 / -1.72%
Today’s Change
56.00
Today|||52-Week Range
125.61
-17.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues1.1M1.0M730.0K5.1M
 
 
 
 
 
Depreciation And Amortization1.2M1.2M2.2M2.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses75.4M83.0M88.6M106.5M
 
 
 
 
 
Research And Development64.6M70.5M74.3M87.1M
 
 
 
 
 
Total Operating Expenses76.6M84.2M90.8M109.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-75.5M-83.1M-90.1M-103.9M
 
 
 
 
 
Interest Expense On Debt14.0K5.0K3.0K2.0K
 
 
 
 
 
Other Expenses2.8M2.8M2.7M4.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-72.7M-80.3M-87.4M-99.7M
 
 
 
 
 
Net Income-72.7M-80.3M-87.4M-99.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.9M44.0M44.1M48.8M
 
 
 
 
 
Shares To Calculate EPS Diluted43.9M44.0M44.1M48.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.66-$1.83-$1.98-$2.04
 
 
 
 
 
EPS Diluted-$1.66-$1.83-$1.98-$2.04